The global orthopedic surgical robots market size is anticipated to reach USD 1.09 billion by 2030 and is projected to grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2030. The market's growth can be attributed to increasing cases of knee and hip replacement surgeries, the introduction of key healthcare companies with robotic trends, and better improvement in patient outcomes. Moreover, the rising incidence of osteoarthritis in developed countries is leading to a surge in joint replacement surgery. According to data published by WHO in July 2022, an estimated 1.71 billion people across the globe have musculoskeletal disorders, with 528 million people suffering from osteoarthritis.
A growing demand for minimally invasive surgeries, as they are less time-consuming and quite effective, is further anticipated to drive the market over the forecast period. Moreover, technological advancements pertaining to the development of image-guided orthopedic systems, such as orthopilots (CT-free navigation system), is also estimated to have a strong influence on market growth over the forecast period.
According to data published by the Australian Bureau of Statistics (ABS) 2020–21 National Health Survey (NHS), around 27% of people in Australia are estimated to have chronic musculoskeletal conditions including back problems (16%), arthritis (12%), and osteoporosis or osteopenia (3.6%).Other factors such as the rising incidence of obesity, leading to increased wear & tear of joints, and a rapidly aging population with increased life expectancy are among factors expected to contribute to the increasing demand for such surgeries, resulting in high demand for surgical robots.
Request a free sample copy or view report summary: Orthopedic Surgical Robots Market Report
Based on the application, the knee segment dominated the orthopedic surgical robots market with the largest share of 43.3% in 2023 owing to the increasing prevalence of osteoarthritis and the rising patient preference for robotic surgery and availability in the market
Based on end-use, the inpatient facilities dominated the market with the largest revenue share of 53.2% in 2023 owing to improved inpatient facilities such as hospitals that usually have financial means and a substantial patient flow to invest in expensive surgical robotic systems
Based on the region, North America dominated the orthopedic surgical robots market in 2023 due to its highly efficient healthcare infrastructure and aged population. Major drivers of the market include improvements in surgeries and healthcare facilities for various disorders
Grand View Research has segmented the global orthopedic surgical robots market based on application, end-use, and region:
Orthopedic Surgical Robots Application Outlook (Revenue, USD Million, 2018 - 2030)
Hip
Knee
Spine
Others
Orthopedic Surgical Robots End-Use Outlook (Revenue, USD Million, 2018 - 2030)
Inpatient
Outpatient
Orthopedic Surgical Robots Regional Outlook (Volume, Units; Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
Italy
France
Spain
Denmark
Sweden
Norway
Asia-Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East Africa
South Africa
Saudi Arabia
UAE
Kuwait
Lis of Key Players in Orthopedic Surgical Robots Market
Medrobotics Corporation
Medtronic
Renishaw plc
Smith and Nephew
Stryker Corporation
THINK Surgical, Inc.
Transenterix (Asensus Surgical, Inc.)
Zimmer Biomet
Accuray Incorporated,
Globus Medical,
Auris Health Inc.,
Johnson & Johnson Services Inc.
Nordson Corporation,
OMNILife science Inc.,
Intuitive Surgical,
Wright Medical Group N
Medrobotics Corporation,
"The quality of research they have done for us has been excellent..."